Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The Ineffectiveness of Magnotherapy in a Patient with Obstructive Sleep Apnea Syndrome and Cardiovascular Comorbidity

  • 57 Accesses


Obstructive sleep apnea syndrome (OSAS) is associated with mild to severe cardiovascular risks. The most common standard treatment for OSAS, continuous positive airway pressure, was found to have beneficial effects on cardiovascular sequelae of OSAS. Additionally, commercial companies promote nonprescription treatments for OSAS. These products frequently lack scientific support for their efficacy and need further research. We report an objective test of magnetic therapy, one such product, in a patient with OSAS and cardiovascular comorbidities. Two nights of polysomnographic recording using the split-night protocol did not reveal any consistent differences in OSAS symptoms whether the patient slept with or without the magnetic equipment. It was concluded that magnetic treatment was unsuccessful in reducing OSAS symptoms in our patient and may even increase possible cardiovascular and stroke risks by preventing the patient from pursuing an adequate medical treatment, such as continuous positive airway pressure.

This is a preview of subscription content, log in to check access.


  1. 1.

    Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230–1235

  2. 2.

    Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. A 7-year follow-up. Am J Respir Crit Care Med 2002;166:159–165

  3. 3.

    Meoli AL, Rosen CL, Kristo D et al. Nonprescription treatments of snoring or obstructive sleep apnea: an evaluation of products with limited scientific evidence. Sleep 2003;26:619–624

  4. 4.

    Edinger JD, Fins AI, Glenn DM et al. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?. J Consult Clin Psychol 2000;68:586–593

  5. 5.

    Bixler EO, Vgontzas AN, Lin H-M et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160:2289–2295

  6. 6.

    Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep-apnea, and hypertension in a large community-based study. JAMA 2000;283:1829–1836

  7. 7.

    Ohayon MM, Guilleminault C, Priest RG, Zulley J, Smirne S. Is sleep-disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects)?. J Psychosom Res 2000;48:593–601

  8. 8.

    Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease. Long-term prognosis. Am J Respir Crit Care Med 2001;164:1910–1913

  9. 9.

    Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke 2001;32:1271–1278

  10. 10.

    Neau J-P, Paquereau J, Meurice J-C, Chavagnat J-J, Gil R. Stroke and sleep apnoea: cause or consequence?. Sleep Med Rev 2002;6:457–469

  11. 11.

    Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T. Nasal continuous positive airway pressure changes blood pressure “non-dippers” to “dippers” in patients with obstructive sleep apnea. Sleep 1999;22:849–853

  12. 12.

    Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68–73

  13. 13.

    Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993;16:545–549

  14. 14.

    Pepperell JC, Ramdassingh-Dow S, Crosthwaite N et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial. Lancet 2002;359:204–210

  15. 15.

    Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep 1996;19:378–381

  16. 16.

    Narciewicz K, Kato M, Phillips BG, Pesek C, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999;100:2332–2335

  17. 17.

    Dexter D. Magnetic therapy is ineffective for the treatment of snoring and obstructive sleep apnea syndrome. Wis Med J 1997;96:35–37

Download references

Author information

Correspondence to Yaron Dagan M.D., D.Sc..

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dagan, Y., Borodkin, K. The Ineffectiveness of Magnotherapy in a Patient with Obstructive Sleep Apnea Syndrome and Cardiovascular Comorbidity. Sleep Breath 8, 209–212 (2004). https://doi.org/10.1007/s11325-004-0209-x

Download citation


  • Obstructive sleep apnea syndrome
  • magnotherapy, cardiovascular comorbidity